A physiological model of the inflammatory-thermal-pain-cardiovascular interactions during a pathogen challenge

A Dobréva(North Carolina State University), Mette S. Olufsen(North Carolina State University), Jesper Mehlsen(Frederiksberg Hospital), Renee Brady‐Nicholls(Moffitt Cancer Center), Charles Puelz(University of Houston), Kamila Larripa(Cal Poly Humboldt)
arXiv (Cornell University)
August 13, 2019
10.48550/arxiv.1908.07611
Cited by 0

Related Papers

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
Numerical Simulation and Experimental Validation of Blood Flow in Arteries with Structured-Tree Outflow Conditions
|Annals of Biomedical Engineering|2000|864
Structured tree outflow condition for blood flow in larger systemic arteries
|American Journal of Physiology-Heart and Circulatory Physiology|1999|440
Blood pressure and blood flow variation during postural change from sitting to standing: model development and validation
|Journal of Applied Physiology|2005|245